Individuals with juvenile polyposis syndrome (JPS) are carriers of mutations in crucial components of the BMP pathway such as the BMP receptor 1a (BMPR1a) or the downstream signaling molecule SMAD4. This evidence concerns the gene SMAD4 and juvenile polyposis syndrome.